Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scientist Home Future HealthSHFH +11.11%8 EBITDA Margin % is -90.48% as of Jun. 2026. GuruFocus rates SHFH with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 667 Healthcare Providers & Services companies, Scientist Home Future Health ranks worse than 91.45% on this metric.
Scientist Home Future Health (OTCPK:SHFH) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Scientist Home Future Health EBITDA Margin % Related Terms
Scientist Home Future Health EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scientist Home Future Health EBITDA Margin % Chart
SHFH vs BHIC, PETS, SCNX: EBITDA Margin % Comparison
For the Pharmaceutical Retailers subindustry, Scientist Home Future Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scientist Home Future Health EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Scientist Home Future Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Scientist Home Future Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scientist Home Future Health (SHFH) has a EBITDA Margin % of -90.48% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Scientist Home Future Health and its competitors. According to the industry distribution chart, Scientist Home Future Health ranks #610 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 91.5%.
Is Scientist Home Future Health's EBITDA Margin % too high?
Scientist Home Future Health's current EBITDA Margin % is -90.48%. Based on the distribution chart, Scientist Home Future Health ranks #610 out of 667 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Scientist Home Future Health has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Scientist Home Future Health's EBITDA Margin % compare to BHIC and PETS?
According to the Healthcare Providers & Services industry distribution chart, Scientist Home Future Health ranks #610 out of 667 companies for EBITDA Margin %. This places Scientist Home Future Health in the lower half of its industry. The industry median EBITDA Margin % is 10.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.23, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Scientist Home Future Health and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scientist Home Future Health's current EBITDA Margin % is -90.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scientist Home Future Health stock overvalued right now?
Scientist Home Future Health (SHFH) has a current EBITDA Margin % of -90.48%. The current EBITDA Margin % is -90.48%. Scientist Home Future Health's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Scientist Home Future Health (SHFH), the current EBITDA Margin % is -90.48% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Scientist Home Future Health Ltd, through its subsidiaries, engages in the retail trading of health supplements and topical creams and provision of physical check-up services in Hong Kong. It focuses on developing sustainable rehabilitation solutions, particularly for degenerative diseases, ensuring that the products not only address current symptoms but also support future, long-term health and recovery. The company has two reportable segments based on business unit, retail trading and service business. The majority of revenue is derived from the Retail Trading segment, which derives revenue from customers by providing health supplements and topical creams. It has two reportable segments based on geographical location: Hong Kong and Non-Hong Kong; key revenue derives from Hong Kong.
8GF Score
Get the complete analysis for SHFH
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHFH has been successfully added to your 
